Position in VTRS
as of Mar 31, 2026
· filed Apr 27, 2026
Position Value
$397,910
-$103,289 QoQ
Shares Held
29,453
-26.8% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2020
22 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in VTRS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026PROFUND ADVISORS LLC holds $17,208,250 across 29 Drug Manufacturers - Specialty & Generic names. VTRS ranks #8 (2.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | UTHR |
UNITED THERAPEUTICS Corp
|
4,687 | $2,779,297 | |
| 2 | ALKS |
Alkermes plc.
|
77,769 | $2,749,911 | |
| 3 | NBIX |
Neurocrine Biosciences Inc
|
17,687 | $2,330,085 | |
| 4 | BCRX |
Biocryst Pharmaceuticals Inc
|
158,462 | $1,508,558 | |
| 5 | ZTS |
Zoetis Inc.
|
6,653 | $786,451 | |
| 6 | ELAN |
Elanco Animal Health Inc
|
22,305 | $533,758 | |
| 7 | HLN |
Haleon plc
|
50,589 | $506,395 | |
| 8 | VTRS |
Viatris Inc
This page
|
29,453 | $397,910 |
All Filings in VTRS
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $397,910 | 29,453 | Shares | Sole | 2026-04-27 | |
| 2025-12-31 | $501,199 | 40,257 | Shares | Sole | 2026-02-06 | |
| 2025-09-30 | $433,857 | 43,824 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $493,462 | 55,259 | Shares | Sole | 2025-08-07 | |
| 2025-03-31 | $502,418 | 57,683 | Shares | Sole | 2025-05-08 | |
| 2024-12-31 | $596,442 | 47,907 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $682,319 | 58,770 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $665,342 | 62,591 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $812,087 | 68,014 | Shares | Sole | 2024-05-08 | |
| 2023-12-31 | $798,138 | 73,697 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $762,641 | 77,347 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $827,022 | 82,868 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $731,716 | 76,062 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $981,699 | 88,203 | Shares | Sole | 2023-02-02 | |
| 2022-09-30 | $784,129 | 92,034 | Shares | Sole | 2022-11-07 | |
| 2022-06-30 | $927,977 | 88,632 | Shares | Sole | 2022-08-01 | |
| 2022-03-31 | $1,041,792 | 95,753 | Shares | Sole | 2022-05-10 | |
| 2021-12-31 | $1,257,085 | 92,911 | Shares | Sole | 2022-02-08 | |
| 2021-09-30 | $1,097,008 | 80,960 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $1,117,478 | 78,200 | Shares | Sole | 2021-08-12 | |
| 2021-03-31 | $1,102,889 | 78,947 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $1,364,440 | 72,809 | Shares | Sole | 2021-02-09 | |
| No filing history on record for this holder in this stock. | ||||||